FTSE Russell Factsheet

FTSE4Good Europe Index

Data as at: 31 July 2020
bmkTitle1

The FTSE4Good Index Series is a tool for investors seeking to invest in companies that FEATURES
demonstrate good sustainability practices. It also supports investors that wish to encourage
positive change in corporate behavior and align their portfolios with their values. To create the Transparency
FTSE4Good Europe Index, the standard FTSE4Good Index Series selection criteria have been Index governance is overseen by the
applied to the FTSE Developed Europe Index. independent FTSE Russell ESG Advisory
10-Year Performance - Total Return Committee, made up of leading global
(EUR) responsible investment market practitioners
240 and experts on global Environmental, Social
220
and Governance (ESG) principles and criteria
200
180
used to determine comparative corporate
160 ESG performance.
140
Criteria
120
100 Companies need to meet a variety of
80
environmental, social and governance
Jul-2010 Jul-2011 Jul-2012 Jul-2013 Jul-2014 Jul-2015 Jul-2016 Jul-2017 Jul-2018 Jul-2019 Jul-2020
Data as at month end criteria to meet the inclusion requirements –
please see www.ftserussell.com for details
FTSE4Good Europe FTSE Developed Europe FTSE4Good Europe 50
Objective

The indexes are designed for use in the

Performance and Volatility - Total Return
creation of index tracking funds, derivatives
Index (EUR) Return % Return pa %* Volatility %** and as performance benchmarks.
3M 6M YTD 12M 3YR 5YR 3YR 5YR 1YR 3YR 5YR
Investability
FTSE4Good Europe 5.4 -11.2 -12.5 -4.9 4.6 4.9 1.5 1.0 26.6 19.1 14.0
Stocks are selected and weighted to ensure
FTSE Developed Europe 5.2 -12.2 -13.3 -6.1 2.8 5.0 0.9 1.0 26.9 19.7 14.4
that the indexes are investable.
FTSE4Good Europe 50 3.2 -10.3 -11.8 -5.4 5.7 2.7 1.9 0.5 25.3 17.6 13.1
Liquidity
* Compound annual returns measured over 3 and 5 years respectively
** Volatility – 1YR based on 12 months daily data. 3YR based on weekly data (Wednesday to Wednesday). 5YR based on monthly data Stocks are screened to ensure that the
indexes are tradable.
Year-on-Year Performance - Total Return
Index % (EUR) 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Availability

FTSE4Good Europe 9.1 -6.3 19.4 21.3 8.4 8.4 2.1 10.6 -9.4 27.7 The indexes are calculated based on price
FTSE Developed Europe 11.6 -8.2 18.4 20.8 7.4 9.3 3.1 11.1 -10.1 26.9 and total return methodologies, available
FTSE4Good Europe 50 4.0 -3.9 16.5 17.8 6.0 6.5 1.3 8.4 -7.8 26.7 end-of-day.

Industry Classification Benchmark

Return/Risk Ratio and Drawdown - Total Return
(ICB)
Index (EUR) Return/Risk Ratio Drawdown (%)
Index constituents are categorized in
1YR 3YR 5YR 10YR 1YR 3YR 5YR 10YR
accordance with the Industry Classification
FTSE4Good Europe -0.2 0.1 0.1 0.5 -34.4 -34.4 -34.4 -34.4
Benchmark (ICB), the global standard for
FTSE Developed Europe -0.2 0.1 0.1 0.5 -35.4 -35.4 -35.4 -35.4
industry sector analysis.
FTSE4Good Europe 50 -0.2 0.2 0.0 0.5 -31.4 -31.4 -31.4 -31.4

Return/Risk Ratio – based on compound annual returns and volatility in Performance and Volatility table
Drawdown - based on daily data

Source: FTSE Russell as at 31 July 2020. Past performance is no guarantee of future results. 1 of 3
Returns shown before the index launch date reflect hypothetical historical performance. Please see disclaimer for important legal information.
FTSE4Good Europe Index Data as at: 31 July 2020

Top 10 Constituents INFORMATION

Constituent Country ICB Sector Net MCap (EURm) Wgt %
Index Universe
Nestle Switzerland Food Producers 289,072 4.61
FTSE Developed Europe Index
Roche Hldgs (GENUS) Switzerland Pharmaceuticals & Biotechnology 204,203 3.25

Novartis (REGD) Switzerland Pharmaceuticals & Biotechnology 150,497 2.40 Index Launch
SAP Germany Software & Computer Services 149,999 2.39 30 July 2001
AstraZeneca UK Pharmaceuticals & Biotechnology 124,408 1.98
Base Date
ASML Holding Netherlands Technology Hardware & Equipment 119,475 1.90
29 June 2001
Sanofi France Pharmaceuticals & Biotechnology 96,360 1.54

LVMH France Personal Goods 91,287 1.45

Base Value

Novo-Nordisk B Denmark Pharmaceuticals & Biotechnology 90,312 1.44 5000

GlaxoSmithKline UK Pharmaceuticals & Biotechnology 83,772 1.33 Investability Screen
Totals 1,399,383 22.30
Actual free float applied and liquidity

Country Breakdown screened

FTSE4Good Europe FTSE Developed Europe Index Calculation

Country No. of Cons Wgt % No. of Cons Wgt % Diff % End-of-day

Austria 7 0.28 8 0.27 0.02 End-of-Day Distribution
Belgium 8 1.34 14 1.56 -0.22
Via FTP and email
Denmark 13 3.56 20 3.71 -0.16
Currency
Finland 14 2.08 16 2.14 -0.06

France 72 17.21 86 16.30 0.92 EUR

Germany 43 12.83 82 14.98 -2.15 Review Dates

Ireland 3 0.31 5 0.42 -0.10 Semi-annually in June and December
Italy 25 3.63 40 3.80 -0.17

Netherlands 22 6.69 31 6.96 -0.27

Norway 11 1.00 16 1.01 -0.02

Poland 7 0.26 14 0.46 -0.20

Portugal 4 0.35 4 0.30 0.05

Spain 24 4.41 26 3.79 0.62

Sweden 36 5.14 48 4.99 0.15

Switzerland 35 17.97 48 16.05 1.91

UK 104 22.94 130 23.26 -0.31

Totals 428 100.00 588 100.00

ICB Industry Breakdown

FTSE4Good Europe FTSE Developed Europe

ICB Code No. of Cons Wgt % No. of Cons Wgt % Diff %

0001 Oil & Gas 18 4.56 24 4.85 -0.29

1000 Basic Materials 35 6.77 43 6.47 0.30

2000 Industrials 76 13.10 119 15.07 -1.97

3000 Consumer Goods 51 18.79 77 18.98 -0.20

4000 Health Care 31 17.35 48 16.52 0.83

5000 Consumer Services 52 6.30 64 5.81 0.50

6000 Telecommunications 18 3.28 22 2.86 0.41

7000 Utilities 24 4.80 29 4.93 -0.13

8000 Financials 105 17.43 135 17.04 0.39

9000 Technology 18 7.63 27 7.46 0.16

Totals 428 100.00 588 100.00

Source: FTSE Russell as at 31 July 2020. Past performance is no guarantee of future results. 2 of 3
Returns shown before the index launch date reflect hypothetical historical performance. Please see disclaimer for important legal information.
FTSE4Good Europe Index Data as at: 31 July 2020

Index Characteristics
Attributes FTSE4Good Europe FTSE Developed Europe
Number of constituents 428 588

Net MCap (EURm) 6,275,636 7,381,679

Dividend Yield % 3.66 3.65

Constituent Sizes (Net MCap EURm)

Average 14,663 12,554

Largest 289,072 289,419

Smallest 173 115

Median 6,270 5,607

Weight of Largest Constituent (%) 4.61 3.92

Top 10 Holdings (% Index MCap) 22.30 18.96

31 July 2020

bmkImage1 bmkImage2 bmkImage3

© 2020 London Stock Exchange Group plc and its applicable group undertakings (the “LSE Group”). The LSE Group includes (1) FTSE International Limited
(“FTSE”), (2) Frank Russell Company (“Russell”), (3) FTSE Global Debt Capital Markets Inc. and FTSE Global Debt Capital Markets Limited (together, “FTSE
Canada”), (4) MTSNext Limited (“MTSNext”), (5) Mergent, Inc. (“Mergent”), (6) FTSE Fixed Income LLC (“FTSE FI”), (7) The Yield Book Inc (“YB”) and (8)
Beyond Ratings S.A.S. (“BR”). All rights reserved.

® ® ® ® ®
FTSE Russell is a trading name of FTSE, Russell, FTSE Canada, MTSNext, Mergent, FTSE FI, YB and BR. “FTSE ”, “Russell ”, “FTSE Russell ”, “MTS ”,
® ® ® ® ®
“FTSE4Good ”, “ICB ”, “Mergent ”, “The Yield Book ”, “Beyond Ratings ” and all other trademarks and service marks used herein (whether registered or
unregistered) are trademarks and/or service marks owned or licensed by the applicable member of the LSE Group or their respective licensors and are
owned, or used under licence, by FTSE, Russell, MTSNext, FTSE Canada, Mergent, FTSE FI, YB or BR. FTSE International Limited is authorised and
regulated by the Financial Conduct Authority as a benchmark administrator.

All information is provided for information purposes only. All information and data contained in this publication is obtained by the LSE Group, from sources
believed by it to be accurate and reliable. Because of the possibility of human and mechanical error as well as other factors, however, such information and
data is provided "as is" without warranty of any kind. No member of the LSE Group nor their respective directors, officers, employees, partners or licensors
Data definitions available from
make any claim, prediction, warranty or representation whatsoever, expressly or impliedly, either as to the accuracy, timeliness, completeness,
merchantability of any information or of results to be obtained from the use of FTSE Russell products, including but not limited to indexes, data and [email protected]
analytics, or the fitness or suitability of the FTSE Russell products for any particular purpose to which they might be put. Any representation of historical data
accessible through FTSE Russell products is provided for information purposes only and is not a reliable indicator of future performance. To learn more, visit www.ftserussell.com;
No responsibility or liability can be accepted by any member of the LSE Group nor their respective directors, officers, employees, partners or licensors for (a)
email [email protected]; or
any loss or damage in whole or in part caused by, resulting from, or relating to any error (negligent or otherwise) or other circumstance involved in call your regional Client Services Team office:
procuring, collecting, compiling, interpreting, analysing, editing, transcribing, transmitting, communicating or delivering any such information or data or from
use of this document or links to this document or (b) any direct, indirect, special, consequential or incidental damages whatsoever, even if any member of
EMEA
the LSE Group is advised in advance of the possibility of such damages, resulting from the use of, or inability to use, such information.
+44 (0) 20 7866 1810
No member of the LSE Group nor their respective directors, officers, employees, partners or licensors provide investment advice and nothing contained
herein or accessible through FTSE Russell products, including statistical data and industry reports, should be taken as constituting financial or investment
advice or a financial promotion. North America

Past performance is no guarantee of future results. Charts and graphs are provided for illustrative purposes only. Index returns shown may not represent
+1 877 503 6437
the results of the actual trading of investable assets. Certain returns shown may reflect back-tested performance. All performance presented prior to the
index inception date is back-tested performance. Back-tested performance is not actual performance, but is hypothetical. The back-test calculations are Asia-Pacific
based on the same methodology that was in effect when the index was officially launched. However, back-tested data may reflect the application of the
index methodology with the benefit of hindsight, and the historic calculations of an index may change from month to month based on revisions to the Hong Kong +852 2164 3333
underlying economic data used in the calculation of the index.
Tokyo +81 3 4563 6346
No part of this information may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, Sydney +61 (0) 2 8823 3521
photocopying, recording or otherwise, without prior written permission of the applicable member of the LSE Group. Use and distribution of the LSE Group
data requires a licence from FTSE, Russell, FTSE Canada, MTSNext, Mergent, FTSE FI, YB, BR and/or their respective licensors.

Source: FTSE Russell as at 31 July 2020. Past performance is no guarantee of future results. 3 of 3
Returns shown before the index launch date reflect hypothetical historical performance. Please see disclaimer for important legal information.